AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
– Alliance will deliver prospect for AbbVie to further more develop its assorted eye treatment portfolio and offer supplemental treatment method options for glaucoma patients– Collaboration further more supports the job of MINIject® in the procedure of glaucoma and accelerates target to carry MINIject to additional patients globally– Offer terms consist of a $60M upfront payment to iSTAR Clinical– iSTAR Healthcare to carry on progress and commercialization of the MINIject machine up to completion of the U.S. PMA research NORTH CHICAGO,…